Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venom
- 1 August 2014
- Vol. 46 (5) , 444-449
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy – Australian Snakebite Project (ASP-19)Clinical Toxicology, 2013
- APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagentJournal of Thrombosis and Haemostasis, 2012
- Bites in Australian snake handlers--Australian snakebite project (ASP-15)QJM: An International Journal of Medicine, 2012
- Recommendations for Appropriate Activated Partial Thromboplastin Time Reagent Selection and UtilizationAmerican Journal of Clinical Pathology, 2012
- Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenomToxicon, 2011
- Lupus Anticoagulant TestingAmerican Journal of Clinical Pathology, 2010
- Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming?Medical Journal of Australia, 2010
- Development of a sensitive enzyme immunoassay for measuring taipan venom in serumToxicon, 2010
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- Anticoagulant proteins from snake venoms: structure, function and mechanismBiochemical Journal, 2006